Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy

Independent validation of tumour volume, cancer stem cell markers and hypoxia-associated gene expressions for HNSCC after primary radiochemotherapy

Objective: To independently validate the impact of tumour volume, p16 status, cancer stem cell (CSC) marker expression and hypoxia-associated gene signatures as potential prognostic biomarkers for patients with locally advanced head and neck squamous cell carcinoma (HNSCC), who underwent primary rad...

Full description

Bibliographic Details
Main Authors:	Annett Linge, Stefan Schmidt, Fabian Lohaus, Constanze Krenn, Anna Bandurska-Luque, Ivan Platzek, Cläre von Neubeck, Steffen Appold, Alexander Nowak, Volker Gudziol, Frank Buchholz, Gustavo B. Baretton, Michael Baumann, Steffen Löck, Mechthild Krause
Format:	Article
Language:	English
Published:	Elsevier 2019-05-01
Series:	Clinical and Translational Radiation Oncology
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405630818301150

Similar Items

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
by: Annett Linge, et al.
Published: (2016-12-01)

Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients
by: Anna Bandurska-Luque, et al.
Published: (2019-02-01)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
by: Treewut Rassamegevanon, et al.
Published: (2021-11-01)

Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy.
by: Nils Cordes, et al.
Published: (2018-01-01)

A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
by: Shivaprasad Patil, et al.
Published: (2022-06-01)

Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
by: Lydia Koi, et al.
Published: (2023-08-01)

Integrated radiogenomics analyses allow for subtype classification and improved outcome prognosis of patients with locally advanced HNSCC
by: Asier Rabasco Meneghetti, et al.
Published: (2022-10-01)

Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
by: Stefan Leger, et al.
Published: (2020-10-01)

Specific requirements for translation of biological research into clinical radiation oncology
by: Mechthild Krause, et al.
Published: (2020-07-01)

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
by: Sarah Meneceur, et al.
Published: (2020-04-01)

SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
by: Chiara De-Colle, et al.
Published: (2017-08-01)

Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
by: Nicole Wiedenmann, et al.
Published: (2018-08-01)

Impact of Blood Parameters and Normal Tissue Dose on Treatment Outcome in Esophageal Cancer Patients Undergoing Neoadjuvant Radiochemotherapy
by: Rebecca Bütof, et al.
Published: (2022-07-01)

Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET
by: Nicole Wiedenmann, et al.
Published: (2018-09-01)

Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal Cancer
by: Felix Wagner, et al.
Published: (2019-03-01)

Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer
by: Armin Jarosch, et al.
Published: (2018-02-01)

Radiomics for residual tumour detection and prognosis in newly diagnosed glioblastoma based on postoperative [11C] methionine PET and T1c-w MRI
by: Iram Shahzadi, et al.
Published: (2024-02-01)

Applying Tissue Slice Culture in Cancer Research—Insights from Preclinical Proton Radiotherapy
by: Theresa Suckert, et al.
Published: (2020-06-01)

Increase in tumor control and normal tissue complication probabilities in advanced head-and-neck cancer for dose-escalated intensity-modulated photon and proton therapy
by: Annika eJakobi, et al.
Published: (2015-11-01)

Epigenetic Targeting to Overcome Radioresistance in Head and Neck Cancer
by: Iñaki Schniewind, et al.
Published: (2024-02-01)

Combined Radiochemotherapy: Metalloproteinases Revisited
by: Verena Waller, et al.
Published: (2021-05-01)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
by: Victor Lewitzki, et al.
Published: (2019-12-01)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
by: Steffi Liebscher, et al.
Published: (2017-02-01)

Relative biological effectiveness in proton beam therapy – Current knowledge and future challenges
by: Armin Lühr, et al.
Published: (2018-02-01)

Late Side Effects in Normal Mouse Brain Tissue After Proton Irradiation
by: Theresa Suckert, et al.
Published: (2021-01-01)

Predictors for Adherence to Treatment Strategies in Elderly HNSCC Patients
by: Raphaela Graessle, et al.
Published: (2022-01-01)

Concurrent radiochemotherapy in advanced hypopharyngeal cancer
by: Lukarski Dusko, et al.
Published: (2010-05-01)

Prognostic value of the micronucleus assay for clinical endpoints in neoadjuvant radiochemotherapy for rectal cancer
by: Leif Hendrik Dröge, et al.
Published: (2021-03-01)

Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy
by: Hauptmann Steffen, et al.
Published: (2006-05-01)

Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
by: Susanne Wiegand, et al.
Published: (2023-03-01)

Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models
by: Iram Shahzadi, et al.
Published: (2022-06-01)

Local Control after Locally Ablative, Image-Guided Radiotherapy of Oligometastases Identified by Gallium-68-PSMA-Positron Emission Tomography in Castration-Sensitive Prostate Cancer Patients (OLI-P)
by: Tobias Hölscher, et al.
Published: (2022-04-01)

[The role of radiochemotherapy in multimodal therapy of pancreatic cancer].
by: Brunner, T, et al.
Published: (2007)

Triapine Radiochemotherapy in Advanced Stage Cervical Cancer
by: Charles A. Kunos, et al.
Published: (2018-05-01)

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas
by: Lina Lüttich, et al.
Published: (2021-04-01)

Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction
by: Sebastian Starke, et al.
Published: (2023-01-01)

Subgroup Analysis of Overall Survival among Smoking and Non-Smoking Elderly Patients with HNSCC
by: Raphaela Graessle, et al.
Published: (2023-03-01)

Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes
by: Macarena Cubillos-Mesías, et al.
Published: (2017-11-01)

Predictive Factors of the Response of Rectal Cancer to Neoadjuvant Radiochemotherapy
by: Anita De Rossi, et al.
Published: (2011-04-01)

RADIOCHEMOTHERAPY FOR ADVANCED HEAD AND NECK CARCINOMA – LJUBLJANA EXPERIENCE
by: Lojze Šmid, et al.
Published: (2002-12-01)